The document discusses several substitution and addition processes involving organic molecules. It describes processes for preparing substituted and unsubstituted cyclopentadienyl compounds, transferring amino acids to tRNA, adding nucleophiles like hydroxide to electron-deficient arenes, converting aniline to acetanilide through acetic anhydride, and proposing a two-step mechanism for nucleophilic substitution involving addition of a nucleophile followed by halide loss. It also discusses processes for preparing the drug imatinib, performing aldol reactions to obtain β-hydroxy aldehydes or ketones, and a methodology useful in synthesizing the drug roxifiban.
The document discusses several substitution and addition processes involving organic molecules. It describes processes for preparing substituted and unsubstituted cyclopentadienyl compounds, transferring amino acids to tRNA, adding nucleophiles like hydroxide to electron-deficient arenes, converting aniline to acetanilide through acetic anhydride, and proposing a two-step mechanism for nucleophilic substitution involving addition of a nucleophile followed by halide loss. It also discusses processes for preparing the drug imatinib, performing aldol reactions to obtain β-hydroxy aldehydes or ketones, and a methodology useful in synthesizing the drug roxifiban.
The document discusses several substitution and addition processes involving organic molecules. It describes processes for preparing substituted and unsubstituted cyclopentadienyl compounds, transferring amino acids to tRNA, adding nucleophiles like hydroxide to electron-deficient arenes, converting aniline to acetanilide through acetic anhydride, and proposing a two-step mechanism for nucleophilic substitution involving addition of a nucleophile followed by halide loss. It also discusses processes for preparing the drug imatinib, performing aldol reactions to obtain β-hydroxy aldehydes or ketones, and a methodology useful in synthesizing the drug roxifiban.
The document discusses several substitution and addition processes involving organic molecules. It describes processes for preparing substituted and unsubstituted cyclopentadienyl compounds, transferring amino acids to tRNA, adding nucleophiles like hydroxide to electron-deficient arenes, converting aniline to acetanilide through acetic anhydride, and proposing a two-step mechanism for nucleophilic substitution involving addition of a nucleophile followed by halide loss. It also discusses processes for preparing the drug imatinib, performing aldol reactions to obtain β-hydroxy aldehydes or ketones, and a methodology useful in synthesizing the drug roxifiban.
transferred from HCl, the acid, to hydroxide, the base. The product is water and chloride ion. You have undoubtedly seen this reaction before in general chemistry. Despite its simplicity, this reaction allows us to consider for the first time many of the fundamental ideas of organic chemistry that we will be exploring in various contexts throughout this text.
Substituted or unsubstituted cyclopentadienyl are prepared by reducing 4-ketocyclopentene to an alcohol, replacing the hydroxyl functionality with a leaving group and deprotonating the resulting product under base induced elimination conditions. The amino acid is transferred to a special kind of RNA polymer called transfer RNA, or tRNA for short. We need not concern ourselves here with the structure of tRNA molecules- all we need to know for now is that the nucleophile in this reaction is a hydroxyl group on the terminal adenosine of tRNA.
Substitution process
Five-membered heterocycles having biphenylsulfonyl substitution, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them. Compounds of the formula I in which the symbols have the meanings indicated in the claims, have outstanding antiarrhythmic properties and exhibit a cardioprotective component. They can preventively inhibit or greatly decrease the pathophysiological processes in the formation of ischemically induced damage, in particular in the elicitation of ischemically induced cardiac arrhythmias. Moreover, they have a potent inhibitory action on the proliferation of cells.
Addition of nucleophiles to electron-deficient arenes, even those containing leaving groups X e.g. halogens, proceeds faster in positions occupied by hydrogen than in those occupied by halogens. Since spontaneous departure of hydride anion from the initially formed H adducts does not proceed and the addition is a reversible process, nucleophilic substitution of halogens (SNAr reaction), proceeding via slower, but irreversible formation of the X adducts is commonly observed process. These relations are exemplified in scheme 1.
If aniline is treated with acetic anhydride, it is converted to acetanilide (Fig. 11-6). The substituent on the ring is now an acetamido group, and is still an ortho, para director, but less strongly activating, so that mono substitution can be carried out easily. The acetyl group can then be removed by hydrolysis if desired ("Carboxylic Acids"). The negative charge on the intermediate is spread out into the benzene ring and onto the ketone by resonance. The resonance form with the charge on oxygen looks very much like the intermediate in carbonyl addition elimination, except that there is a benzene ring between the nucleophile and the carbonyl.
Addition process
a third mechanism for nucleophilic substitution has been proposed. This two-step mechanism is characterized by initial addition of the nucleophile (hydroxide ion or water) to the aromatic ring, followed by loss of a halide anion from the negatively charged intermediate as illustrated below. The sites over which the negative charge is delocalized are colored blue, and the ability of nitro, and other electron withdrawing, groups to stabilize adjacent negative charge accounts for their rate enhancing influence at the ortho and para locations.
Three additional examples of aryl halide nucleophilic substitution are presented below. Only the 2- and 4- chloropyridine isomers undergo rapid substitution, the 3- chloro isomer is relatively unreactive. Nitrogen nucleophiles will also react, as evidenced by the use of Sanger's reagent for the derivatization of amino acids. The resulting N-2,4-dinitrophenyl derivatives are bright yellow crystalline compounds that facilitated analysis of peptides and proteins.
The process comprises a step wherein a crude solution of the pro-drug ester is subjected to an evaporation which is controlled by the evaporation rate of the organic solvent such that a continuous operation is accomplished for the crystallization of the desired purified pro-drug ester or salt thereof. Said crystallization is preferably preceded by an aqueous phase extraction and/or an organic phase extraction, both preferably also being performed continuously.
Addition process
A process of preparing imatinib, either as the free base or as an acid addition salt, which process comprises reacting N-(2-methyl-5-aminophenyl-4-(3-pyridyl)-2-pyrimidine amine of formula (II) with a 4-(4-methyl-piperazino methyl)benzoyl halide of formula (III) in the presence of an inert organic solvent, so as to yield a hydrohalide salt of imatinib formula (I) where n represents 1, 2 or 3 and Hal represents bromo, chloro, fluoro or iodo, either in anhydrous or hydrated form, which can as desired optionally be further converted either to the free base or a further acid addition salt. The present invention is also concerned with imatinib prepared according to the above process. 'Aldol' is an abbreviation of aldehyde and alcohol. When the enolate of an aldehyde or a ketone reacts at the - carbon with the carbonyl of another molecule under basic or acidic conditions to obtain -hydroxy aldehyde or ketone, this reaction is called Aldol Reaction. This methodology is useful in the synthesis of roxifiban, a drug in development for a range of cardiovascular disorders arising from undesired platelet adhesion.